Acadia Healthcare Company, Inc. $ACHC Shares Purchased by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. grew its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 85.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,683 shares of the company’s stock after acquiring an additional 13,188 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Acadia Healthcare were worth $651,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in ACHC. GAMMA Investing LLC grew its holdings in Acadia Healthcare by 143.8% during the 1st quarter. GAMMA Investing LLC now owns 5,812 shares of the company’s stock worth $176,000 after acquiring an additional 3,428 shares in the last quarter. Caxton Associates LLP acquired a new position in Acadia Healthcare in the first quarter valued at approximately $394,000. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Acadia Healthcare by 256.4% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock valued at $591,000 after buying an additional 18,742 shares in the last quarter. Janney Montgomery Scott LLC acquired a new position in Acadia Healthcare in the second quarter valued at $479,000. Finally, PNC Financial Services Group Inc. boosted its position in shares of Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock valued at $202,000 after purchasing an additional 622 shares during the period.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ACHC. KeyCorp decreased their price target on shares of Acadia Healthcare from $55.00 to $35.00 and set an “overweight” rating for the company in a research note on Wednesday, October 8th. Cantor Fitzgerald restated a “neutral” rating and issued a $25.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 7th. Guggenheim reduced their price objective on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Raymond James Financial raised their target price on Acadia Healthcare from $26.00 to $30.00 and gave the company an “outperform” rating in a report on Friday, October 3rd. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $35.09.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $21.50 on Friday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 12-month low of $17.13 and a 12-month high of $47.08. The stock has a market cap of $1.99 billion, a P/E ratio of 14.24, a PEG ratio of 4.56 and a beta of 0.90. The company has a 50-day moving average of $23.52 and a two-hundred day moving average of $22.87.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same period in the previous year, the firm posted $0.91 EPS. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.